Advertisement

Topics

Oxford Genetics and Cell and Gene Therapy Catapult collaborate to develop scalable gene therapy manufacturing processes

08:38 EDT 13 May 2019 | Synbiobeta

13 May, 2019 – Oxford.   Oxford Genetics announces a collaboration with the Cell and Gene Therapy Catapult (CGT Catapult) to develop scalable Lentiviral manufacturing processes based on Oxford Genetics’ proprietary Lentiviral production technology, and stable cell line solutions. Oxford Genetics technologies aim to deliver transformational solutions to the cell and gene therapy industry, enabling the […]

The post Oxford Genetics and Cell and Gene Therapy Catapult collaborate to develop scalable gene therapy manufacturing processes appeared first on SynBioBeta.

Original Article: Oxford Genetics and Cell and Gene Therapy Catapult collaborate to develop scalable gene therapy manufacturing processes

NEXT ARTICLE

More From BioPortfolio on "Oxford Genetics and Cell and Gene Therapy Catapult collaborate to develop scalable gene therapy manufacturing processes"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Collaborations in biotechnology
Commercial and academic collaborations are used throughout the biotechnology and pharmaceutical sector to enhance research and product development. Collaborations can take the form of research and evaluation agreements, licensing, partnerships etc. ...

Biological Therapy
Biological therapy involves the use of living organisms, substances derived from living organisms, or laboratory-produced versions of such substances to treat disease. Some biological therapies for cancer use vaccines or bacteria to stimulate the body&rs...